Cho Won-Chul, Yoo Dong Gon, Kim Joon Bum, Lee Seung Hyun, Jung Sung Ho, Chung Cheol Hyun, Lee Jae Won, Choo Suk Jung
Department of Thoracic and Cardiovascular Surgery, Gangneung Asan Hospital, University of Ulsan, College of Medicine, Seoul, Korea.
J Card Surg. 2011 Nov;26(6):579-85. doi: 10.1111/j.1540-8191.2011.01314.x. Epub 2011 Oct 5.
The aim of this study was to compare the results of all arterial multivessel coronary artery bypass grafting using the left internal thoracic artery composite bypass graft constructed with the right internal thoracic artery or radial artery.
Patients undergoing coronary artery bypass grafting with a left internal thoracic artery constructed as a composite bypass graft with either a right internal thoracic artery (n = 45; RITA group) or radial artery (n = 352; RA group) between 2003 and 2009 were included in the present study.
The three-year patency rates for the RITA and RA groups were 91.8%± 4.3% and 78.6%± 3.4%, respectively (p = 0.12). Adjustments for covariates revealed the radial artery patency to be significantly inferior to the right internal thoracic artery graft (hazard ratio 4.35, 95% confidence interval 1.05 to 18.0; p = 0.043). Reintervention for target coronary artery occlusion was required in two patients in the RA group over a mean follow-up period of 35.5 ± 21.5 months. There were 43 deaths in the entire cohort of which 20 were cardiac. After adjustment for significant variables, the risk of all-cause mortality, cardiac death, and the composite of adverse events (death, reintervention, myocardial infarction, and stroke) were similar for the two groups (p = 0.98, 0.99, and 0.21, respectively).
Although superior patency was observed with the right internal thoracic artery over the radial artery graft, a significant commensurate benefit in reducing the incidence of major adverse clinical outcomes was not necessarily shown.
本研究旨在比较使用由右乳内动脉或桡动脉构建的左乳内动脉复合旁路移植术进行全动脉多支冠状动脉旁路移植术的结果。
纳入2003年至2009年间接受冠状动脉旁路移植术的患者,这些患者使用右乳内动脉(n = 45;RITA组)或桡动脉(n = 352;RA组)构建左乳内动脉复合旁路移植术。
RITA组和RA组的三年通畅率分别为91.8%±4.3%和78.6%±3.4%(p = 0.12)。对协变量进行调整后发现,桡动脉通畅性明显低于右乳内动脉移植物(风险比4.35,95%置信区间1.05至18.0;p = 0.043)。在平均随访期35.5±21.5个月内,RA组有2名患者因靶冠状动脉闭塞需要再次干预。整个队列中有43例死亡,其中20例为心源性死亡。在对显著变量进行调整后,两组的全因死亡率、心源性死亡风险以及不良事件(死亡、再次干预、心肌梗死和中风)的复合风险相似(分别为p = 0.98、0.99和0.21)。
尽管观察到右乳内动脉的通畅性优于桡动脉移植物,但在降低主要不良临床结局发生率方面不一定显示出相应的显著益处。